Clinical trials with N-isopropyl-α-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia
- 1 August 1967
- Vol. 20 (8), 1187-1194
- https://doi.org/10.1002/1097-0142(196708)20:8<1187::aid-cncr2820200802>3.0.co;2-s
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Monoamine Oxidase Inhibition by a New Carcinostatic Agent, N-Isopropyl- -(2-Methylhydrazino)-p-Toluamide (MIH)Experimental Biology and Medicine, 1965
- Natulan in Management of Late Hodgkin's Disease, Other Lymphoreticular Neoplasms, and Malignant MelanomaBMJ, 1965
- Cytostatischer Wirkungsmechanismus der MethylhydrazineCellular and Molecular Life Sciences, 1964
- METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HÆMATOSARCOMA AND LEUKÆMIAThe Lancet, 1963
- Verlängerte Überlebenszeit von Hauthomotransplantaten bei Mäusen durch ein MethylhydrazinderivatCellular and Molecular Life Sciences, 1963
- The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: The intermediate formation of hydrogen peroxideCellular and Molecular Life Sciences, 1963
- Cytological investigations with a new class of cytotoxic agents: Methylhydrazine derivativesCellular and Molecular Life Sciences, 1963
- Tumour inhibitory effects of a new class of cytotoxic agents: Methylhydrazine derivativesCellular and Molecular Life Sciences, 1963
- Methylhydrazine derivatives, a new class of cytotoxic agentsCellular and Molecular Life Sciences, 1963
- Studies on the folic acid vitamins.II. The Acute toxicity of amethopterin in manCancer, 1960